A synthetic peptide of 15 amino acids (Body Protection Compound-157), derived from a gastric-juice protein and studied mainly in animal models of tissue repair.

It is not approved as a medicine, so it cannot be sold for human use. It is sold as a laboratory research reagent, which is what SanaPept does. It is prohibited in sport (WADA, class S0).

Did the FDA approve BPC-157 in 2026?

No. The FDA removed it from its category 2 list in April 2026 and its advisory committee narrowly backed compounding in July 2026, but the FDA has not made a final decision. BPC-157 is still not an approved drug.

What is the difference between BPC-157 and TB-500?

BPC-157 is a 15-amino-acid fragment of a gastric protein. TB-500 refers to synthetic thymosin beta-4 (43 amino acids) or a fragment of it. They are often studied together, in blends such as Wolverine.

Where can I buy BPC-157 for research?

SanaPept sells lyophilized BPC-157 in boxes of 10 vials of 5 or 10 mg, from €1.69/mg, with an independent COA (measured purity up to 99.82%). Delivery within 15 days across Europe, payment in cryptocurrency. For laboratory research only.

Molecule guide

BPC-157: what it is, what research shows, legal status

Updated November 9, 2026

Short answer

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a protein in human gastric juice. It has been studied since the 1990s, mostly in rodents, in models of tendon, muscle, gut and blood-vessel injury. It is not approved as a medicine anywhere and is on the World Anti-Doping Agency’s prohibited list. SanaPept sells it for research, from €1.69/mg, with measured purity up to 99.82%.

Key facts

Other names	Body Protection Compound-157, BPC 157, PL 14736
Type	Synthetic peptide of 15 amino acids
Origin	Fragment of a protein from human gastric juice; studied since the early 1990s by Predrag Sikirić’s team (University of Zagreb)
Sequence	Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular formula	C62H98N16O22
Molecular weight	1,419.5 g/mol
CAS number	137525-51-0
Status (Nov. 2026)	Not approved as a medicine (EU, US); removed from FDA category 2 in April 2026, final FDA decision on compounding pending
Anti-doping (WADA)	Prohibited at all times (class S0, non-approved substances)
At SanaPept	5 and 10 mg per vial, from €1.69/mg, measured purity up to 99.82%; also in Wolverine, GLOW and KLOW

Where does BPC-157 come from?

BPC stands for “Body Protection Compound”, a name given to a protein isolated from gastric juice. BPC-157 reproduces a 15-amino-acid fragment of it. It is stable in gastric juice, so animal studies have tested it both orally and by injection. Most of the work comes from Predrag Sikirić’s group at the University of Zagreb.

What does the research show?

Tendon, ligament and muscle injury models: faster healing in many rat studies.
Digestive models: protection of the gastric and intestinal lining (ulcers, fistulas, experimental colitis).
Proposed mechanisms: angiogenesis, the nitric oxide (NO) pathway and growth-factor signalling (VEGF, EGR-1).
In humans: very little data. Only a few small clinical studies have been run, and no large randomised trial has been published.

Legal status in 2026

BPC-157 is not approved as a medicine in Europe or the United States. In 2023 the FDA put it in category 2 (substances raising safety concerns for compounding); it was removed in April 2026, and in July 2026 the FDA’s advisory committee narrowly voted in favour of allowing it in compounding. The FDA has not ruled yet. In sport, WADA prohibits it at all times (class S0).

Research BPC-157 at SanaPept

SanaPept supplies lyophilized BPC-157 in 5 and 10 mg vials, in boxes of 10 from €99, down to €1.69/mg. Both strengths have a published Amino Metrics COA (HPLC), with purity up to 99.82%. BPC-157 is also available combined with TB-500 (Wolverine) and in the GLOW and KLOW blends.

SanaPept research vials

Boxes of 10 vials, lyophilized, for laboratory research only. Each lot has an independent certificate of analysis.

BPC-157 · 5 mg, 10 mg · from €1.69/mg · box of 10 vials from €99COA: AM-2609-0650 (5mg, 99.56%), AM-2609-0651 (10mg, 99.82%)
Wolverine (BPC-157 + TB-500) 5 + 5 mg · 10 mg · from €2.89/mg · box of 10 vials from €289COA pending
Wolverine (BPC-157 + TB-500) 10 + 10 mg · 20 mg · from €2.80/mg · box of 10 vials from €559COA pending
TB-500 · 2 mg, 5 mg, 10 mg · from €4.19/mg · box of 10 vials from €109COA pending

Frequently asked questions

What is BPC-157?: A synthetic peptide of 15 amino acids (Body Protection Compound-157), derived from a gastric-juice protein and studied mainly in animal models of tissue repair.
Is BPC-157 legal?: It is not approved as a medicine, so it cannot be sold for human use. It is sold as a laboratory research reagent, which is what SanaPept does. It is prohibited in sport (WADA, class S0).
Did the FDA approve BPC-157 in 2026?: No. The FDA removed it from its category 2 list in April 2026 and its advisory committee narrowly backed compounding in July 2026, but the FDA has not made a final decision. BPC-157 is still not an approved drug.
What is the difference between BPC-157 and TB-500?: BPC-157 is a 15-amino-acid fragment of a gastric protein. TB-500 refers to synthetic thymosin beta-4 (43 amino acids) or a fragment of it. They are often studied together, in blends such as Wolverine.
Where can I buy BPC-157 for research?: SanaPept sells lyophilized BPC-157 in boxes of 10 vials of 5 or 10 mg, from €1.69/mg, with an independent COA (measured purity up to 99.82%). Delivery within 15 days across Europe, payment in cryptocurrency. For laboratory research only.

Related guides

Sources

Information based on the public sources listed above. SanaPept products are reagents for laboratory research only, not for human or veterinary use. This page is not medical advice.